Cardiac Science Wins Major Corporate AED Deployment Contracts
BOTHELL, Wash, Jan. 30 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, today highlighted two high-profile contracts secured by its corporate accounts sales team. With these contracts, Cardiac Science will supply Powerheart(R) automated external defibrillators (AEDs) and program management services to hundreds of locations worldwide.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO
"Our global corporate deployment capabilities are at the heart of our AED sales strategy. These recent wins demonstrate our continued success in this area," said John Hinson, Cardiac Science president and chief executive officer.
Fifteen minutes after a Cummins Engine employee learned how to use a Powerheart AED, he saved a colleague's life.
"There is a real need for accessible defibrillation in the workplace," added Mr. Hinson. "According to the Occupational Safety & Health Administration, 15% of all workplace fatalities are sudden cardiac arrests. That we were able to play such a vital role in a life saving event so soon after deployment underscores the value and importance of the products and services we provide. We applaud Cummins and CH2M HILL for their commitment to creating heart safe environments at their locations worldwide."
Cardiac Science's global program management services help customers comply with applicable regulatory requirements and practical logistics issues concerning AED placement and usage. This includes American Heart Association certified training, meticulous record keeping, and a licensed physician to oversee the program.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), Powerheart(R), Quinton(R), and HeartCentrix(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in the North America, Europe, and Asia. For information, call 425-402-2000 or visit http://www.cardiacscience.com.
Forward-Looking Statements
This press release contains forward-looking statements including, but not limited to, those that infer that Cardiac Science Corporation's future revenue and profits may grow as a result of sales of defibrillation products. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2006. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
cgale@evcgroup.com
CONTACT: Mike Matysik, Sr. Vice President and CFO of Cardiac Science
Corporation, +1-425-402-2009; or investors, Jenifer Kirtland,
+1-415-896-6820, or media, Christopher Gale, +1-201-646-5431,
+1-203-570-4681, cgale@evcgroup.com, both of EVC Group, Inc. for Cardiac
Science Corporation
Web site: http://www.cardiacscience.com//